KEHKESHAN SHAH: Open Payments
NPI 1255694436 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 38 payments from 7 companies in 2025. Trend: 2023 $697 · 2024 $1,026 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $346 |
| Novo Nordisk Inc | 13 | $304 |
| Amgen Inc. | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Lilly USA, LLC | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: QULIPTA, Wegovy, Rybelsus, OTEZLA, Ozempic, AIRSUPRA, JARDIANCE, VRAYLAR.
Industry payments across PA — which companies pay providers there.
